Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2025-12-25 @ 7:25 PM
Study NCT ID:
NCT00295932
Status:
COMPLETED
Last Update Posted:
2018-11-20
First Post:
2006-02-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-23
First Submit QC Date:
None
Study First Post Date:
2006-02-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-11
Results First Submit QC Date:
None
Results First Post Date:
2018-11-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-15
Last Update Post Date:
2018-11-20
Last Update Post Date Type:
ACTUAL